| Title: |
The mortality of COVID-19 in CML patients from 2020 until 2022: results from the EPICOVIDEHA survey |
| Authors: |
El-Ashwah, Shaimaa; Salmanton-García, Jon; Bilgin, Yavuz M.; Itri, Federico; Žák, Pavel; Weinbergerová, Barbora; Verga, Luisa; Omrani, Ali S.; Silva, Maria Gomes Da; Szotkowski, Tomáš; Marchetti, Monia; Buquicchio, Caterina; Nucci, Márcio Luiz Moore; Schönlein, Martin; Farina, Francesca; Besson, Caroline M.; Prezioso, Lucia; Nizamuddin, Summiya; Dávila-Valls, Julio; Martín-Pérez, Sonia; Bonuomo, Valentina; van Doesum, Jaap A.; Tisi, Maria Chiara; Passamonti, Francesco; Méndez, Gustavo Adolfo; Meers, Stef; Maertens, Johan A.; López-García, Alberto; Glenthøj, Andreas Birkedal; Bonnani, Matteo; Rinaldi, Ikhwan; Ormazabal-Vélez, Irati; Labrador, Jorge; Kulasekararaj, Austin Gladston; Espigado, Ildefonso; Demirkan, Fatih; de Jonge, Nick A.; Collins, Graham Peter; Calbacho, María; Blennow, Ola; Al-Khabori, Murtadha K.; Adžić-Vukičević, Tatjana N.; Arellano, Elena; Mišković, Bojana; Mladenović, Miloš; Nordlander, Anna; Ráčil, Zdeněk; Ammatuna, Emanuele; Cordoba, Raúl; Hersby, Ditte Stampe; Gräfe, Stefanie K.; Emarah, Ziad A.; Hanakova, Michaela; Sacchi, Maria Vittoria; Ijaz, Marriyam; Rahimli, Laman; Nunes Rodrigues, Raquel; Zambrotta, Giovanni Paolo Maria; Marchesi, F.; Cornely, Oliver A.; Pagano, Livio |
| Contributors: |
Centre de recherche en épidémiologie et santé des populations (CESP); Université de Versailles Saint-Quentin-en-Yvelines (UVSQ)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Hôpital Paul Brousse; AP-HP. Université Paris Saclay-AP-HP. Université Paris Saclay-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université Paris-Saclay; Centre Hospitalier de Versailles André Mignot (CHV); This work was supported by Optics COMMIT (COVID-19 Unmet Medical Needs and Associated Research Extension) COVID-19 RFP program by GILEAD Science, United States 2020-8223 . |
| Source: |
ISSN: 1042-8194. |
| Publisher Information: |
CCSD; Taylor & Francis |
| Publication Year: |
2023 |
| Collection: |
Université de Versailles Saint-Quentin-en-Yvelines: HAL-UVSQ |
| Subject Terms: |
Chronic myeloid leukemia; COVID-19; neoplasia; SARS-CoV-2; tirosine kinase inhibitor; vaccines; [SDV]Life Sciences [q-bio] |
| Description: |
International audience ; Since the beginning of the COVID-19 pandemic, there has been an overall improvement in patient mortality. However, haematological malignancy patients continue to experience significant impacts from COVID-19, including high rates of hospitalization, intensive care unit (ICU) admissions, and mortality. In comparison to other haematological malignancy patients, individuals with chronic myeloid leukemia (CML) generally have better prognosis. This study, conducted using a large haematological malignancy patient database (EPICOVIDEHA), demonstrated that the majority of CML patients experienced mild infections. The decline in severe and critical infections over the years can largely be attributed to the widespread administration of vaccinations and the positive response they elicited. Notably, the mortality rate among CML patients was low and exhibited a downward trend in subsequent years. Importantly, our analysis provided confirmation of the effectiveness of vaccinations in CML patients. |
| Document Type: |
article in journal/newspaper |
| Language: |
English |
| DOI: |
10.1080/10428194.2023.2280886 |
| Availability: |
https://hal.science/hal-04342434; https://hal.science/hal-04342434v1/document; https://hal.science/hal-04342434v1/file/The%20mortality%20of%20COVID-19%20in%20CML%20patients%20from%202020%20until%202022%20results%20from%20the%20EPICOVIDEHA%20survey.pdf; https://doi.org/10.1080/10428194.2023.2280886 |
| Rights: |
http://creativecommons.org/licenses/by/ ; info:eu-repo/semantics/OpenAccess |
| Accession Number: |
edsbas.E4EC43A1 |
| Database: |
BASE |